138 related articles for article (PubMed ID: 22524268)
1. Is S-nitrosylation of cochlear proteins a critical factor in cisplatin-induced ototoxicity?
Jamesdaniel S; Manohar S; Hinduja S
Antioxid Redox Signal; 2012 Oct; 17(7):929-33. PubMed ID: 22524268
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.
Jamesdaniel S; Coling D; Hinduja S; Ding D; Li J; Cassidy L; Seigel GM; Qu J; Salvi R
J Biol Chem; 2012 May; 287(22):18674-86. PubMed ID: 22493493
[TBL] [Abstract][Full Text] [Related]
3. Transient Receptor Potential Channels and Auditory Functions.
Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
[No Abstract] [Full Text] [Related]
4. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
5. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
Jamesdaniel S; Rathinam R; Neumann WL
Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
[TBL] [Abstract][Full Text] [Related]
6. Downstream targets of Lmo4 are modulated by cisplatin in the inner ear of Wistar rats.
Jamesdaniel S
PLoS One; 2014; 9(12):e115263. PubMed ID: 25501662
[TBL] [Abstract][Full Text] [Related]
7. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.
Schweitzer VG
Laryngoscope; 1993 Apr; 103(4 Pt 2):1-52. PubMed ID: 8464301
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
10. Lmo4 Deficiency Enhances Susceptibility to Cisplatin-Induced Cochlear Apoptosis and Hearing Loss.
Rosati R; Shahab M; Ramkumar V; Jamesdaniel S
Mol Neurobiol; 2021 May; 58(5):2019-2029. PubMed ID: 33411315
[TBL] [Abstract][Full Text] [Related]
11. Calpain mediated cisplatin-induced ototoxicity in mice.
Chang L; Wang A
Neural Regen Res; 2013 Jul; 8(21):1995-2002. PubMed ID: 25206508
[TBL] [Abstract][Full Text] [Related]
12. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
[TBL] [Abstract][Full Text] [Related]
13. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
14. MATE1 expression in the cochlea and its potential involvement in cisplatin cellular uptake and ototoxicity.
Waissbluth S; Martínez AD; Figueroa-Cares C; Sánchez HA; Maass JC
Acta Otolaryngol; 2023 Mar; 143(3):242-249. PubMed ID: 36943799
[TBL] [Abstract][Full Text] [Related]
15. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
[TBL] [Abstract][Full Text] [Related]
16. Supporting Cells and Their Potential Roles in Cisplatin-Induced Ototoxicity.
Waissbluth S; Maass JC; Sanchez HA; Martínez AD
Front Neurosci; 2022; 16():867034. PubMed ID: 35573297
[TBL] [Abstract][Full Text] [Related]
17. Role of the copper transporter, CTR1, in platinum-induced ototoxicity.
More SS; Akil O; Ianculescu AG; Geier EG; Lustig LR; Giacomini KM
J Neurosci; 2010 Jul; 30(28):9500-9. PubMed ID: 20631178
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein nitration prevents cisplatin-induced inactivation of STAT3 and promotes anti-apoptotic signaling in organ of Corti cells.
Rosati R; Shahab M; Neumann WL; Jamesdaniel S
Exp Cell Res; 2019 Aug; 381(1):105-111. PubMed ID: 31078568
[TBL] [Abstract][Full Text] [Related]
19. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
